DK1708716T3 - Oralt slankepræparat som omfatter konjugeret linolsyre og coffein - Google Patents

Oralt slankepræparat som omfatter konjugeret linolsyre og coffein

Info

Publication number
DK1708716T3
DK1708716T3 DK05717490T DK05717490T DK1708716T3 DK 1708716 T3 DK1708716 T3 DK 1708716T3 DK 05717490 T DK05717490 T DK 05717490T DK 05717490 T DK05717490 T DK 05717490T DK 1708716 T3 DK1708716 T3 DK 1708716T3
Authority
DK
Denmark
Prior art keywords
caffeine
linoleic acid
conjugated linoleic
diet composition
oral diet
Prior art date
Application number
DK05717490T
Other languages
Danish (da)
English (en)
Inventor
Bernadette Verneau
Original Assignee
Inst Phytoceutic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Phytoceutic filed Critical Inst Phytoceutic
Application granted granted Critical
Publication of DK1708716T3 publication Critical patent/DK1708716T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
DK05717490T 2004-01-27 2005-01-26 Oralt slankepræparat som omfatter konjugeret linolsyre og coffein DK1708716T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0400739A FR2865402B1 (fr) 2004-01-27 2004-01-27 Composition amaigrissante par voie orale comprenant de l'acide linoleique conjugue et de la cafeine.
PCT/FR2005/000166 WO2005082371A2 (fr) 2004-01-27 2005-01-26 Composition amaigrissante par voie orale comprenant de l’acide linoleique conjugue et de la cafeine

Publications (1)

Publication Number Publication Date
DK1708716T3 true DK1708716T3 (da) 2007-10-08

Family

ID=34717436

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05717490T DK1708716T3 (da) 2004-01-27 2005-01-26 Oralt slankepræparat som omfatter konjugeret linolsyre og coffein

Country Status (10)

Country Link
US (2) US20070269533A1 (de)
EP (1) EP1708716B1 (de)
AT (1) ATE368465T1 (de)
CA (1) CA2554435A1 (de)
DE (1) DE602005001849T2 (de)
DK (1) DK1708716T3 (de)
ES (1) ES2288296T3 (de)
FR (1) FR2865402B1 (de)
PT (1) PT1708716E (de)
WO (1) WO2005082371A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2596311A1 (en) * 2005-01-20 2006-07-27 Stephen Holt Herbal compositions containing hoodia
US8097286B2 (en) * 2005-11-04 2012-01-17 Inqpharm Sdn Bhd Herbal composition weight management
US20090246326A1 (en) * 2008-03-25 2009-10-01 Empty Nest Ideas, Llc Coffee product and method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5802499A (en) * 1998-09-01 2000-03-21 Amway Corporation Diet composition and method of weight management
ITMI991894A1 (it) * 1999-09-09 2001-03-09 Carlo Ghisalberti Acido linoleico coniugato e trigliceride nuovi metodi di sintesi e d'uso
WO2001060331A2 (en) * 2000-02-15 2001-08-23 Zen-Bio, Inc. Compositions for preventing cellulite in mammalian skin

Also Published As

Publication number Publication date
US20100041679A1 (en) 2010-02-18
FR2865402B1 (fr) 2006-04-28
US20070269533A1 (en) 2007-11-22
WO2005082371A3 (fr) 2006-01-05
DE602005001849T2 (de) 2007-12-13
CA2554435A1 (fr) 2005-09-09
WO2005082371A2 (fr) 2005-09-09
ATE368465T1 (de) 2007-08-15
PT1708716E (pt) 2007-10-02
FR2865402A1 (fr) 2005-07-29
DE602005001849D1 (de) 2007-09-13
EP1708716A2 (de) 2006-10-11
EP1708716B1 (de) 2007-08-01
ES2288296T3 (es) 2008-01-01

Similar Documents

Publication Publication Date Title
WO2003061584A3 (en) Novel substituted benzimidazole dosage forms and method of using same
NO20100250L (no) Farmasoytisk preparat som innbefatter en S1P reseptoragonist og en sukkeralkohol, og framgangsmate til fremstilling derav
WO2005076987A3 (en) Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent
DE60325839D1 (de) Mit 40-o-(2-hydroxy)ethyl-rapamycin beschichteter stent
TW200514579A (en) Orally dissolving films
SG170826A1 (en) Oral dosage forms including an antiplatelet agent and an acid inhibitor
NO20080220L (no) Formuleringer med hoy medikament belastning og doseringsformer
WO2003082260A3 (en) Tuberculosis treatment using pleuromutilin derivatives
NO20050060L (no) Medikament for behandling av overaktiv blaere
CL2007002000A1 (es) Preparacion farmaceutica para la administracion oral con liberacion controlada de ingrediente activo en el intestino delgado que comprende portadores inertes, ingredientes activo, una capa interna compuesta de 2 capas de difusion para controlar la liberacion y una capa gastrorresistente; metodo de preparacion.
PT1185253E (pt) Forma de administracao oral para administracao de uma combinacao fixa de tramadol e diclofenac
DK1476470T3 (da) Stivelsesderivater, stivelse-aktivstof-konjugater, fremgangsmåde til fremstilling af disse og anvendelse af disse som lægemidler
BR0315604A (pt) Composição de liberação controlada para administração oral de drogas
EP1635218A3 (de) Lichtempfindliche Zusammensetzung, in dieser Zusammensetzung verwendete Verbindung, und Verfahren zur Herstellung von Mustern unter Verwendung dieser Zusammensetzung
NO20051654L (no) Forlenget frigjoring av farmasoytisk preparat
DK1532986T3 (da) Farmaceutisk sammensætning til behandling af rhinitis
WO2008128191A3 (en) Oral cephalotaxine dosage forms
WO2005107753A3 (en) Naltrexone long acting formulations and methods of use
DK1708716T3 (da) Oralt slankepræparat som omfatter konjugeret linolsyre og coffein
DK1318820T3 (da) Lægemiddel indeholdende xenon i subanæstetiske koncentrationer til anvendelse som hjerte-kredslöbsmiddel
WO2005094265A3 (en) Self assembling activation agents targeted using active drug release
WO2005020954A3 (en) Proton pump inhibitor formulations, and methods of preparing and using such formulations
AU2002256775A1 (en) Therapeutic method for inducing tolerance
DK1553943T3 (da) Anvendelse af tenatoprazol til behandling af gastroösofageal refluks
ATE328587T1 (de) Feste pharmazeutische zusammensetzung enthaltend tilidinhydrochlorid